Clinical Trial Update: Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of riluzole in women with-stage I to IIIA breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Breast Cancer | Phase 1 | Status: WITHDRAWN